NVIDIA has indicated that it will delegate its SaturnV supercomputer to be used in COVID-19 relief efforts. The SaturnV supercomputer will be used for research purposes. The allocation of resources comes as NIVIDA joined the COVID-19 High Performance Computing Consortium group, which aims to give researchers the necessary tools.
Overall it is clear that NIVIDA is attempting to provide what it can to empower the treatment efforts for COVID-19. Additionally, the company contributed 27,000 GPUs to the Summit Supercomputer which is also working to improve research efforts related to COVID-19.
NIVIDIA also released a statement about the efforts, "Achieving progress will ultimately require combining three essential ingredients – domain scientists, computer scientists, and high-performance computers. We’re honored to play a role in this effort."
Virus Supercomputer Projects
NIVIDIA's SaturnV Supercomputer Will Be Used for COVID-19 Research
Trend Themes
1. Supercomputer Allocation for COVID-19 Research - NVIDIA's SaturnV supercomputer will be used for COVID-19 research as part of the COVID-19 High Performance Computing Consortium group, presenting an opportunity for more efficient and effective research towards solutions and treatments.
2. Collaborative Research Efforts - The formation and participation of the COVID-19 High Performance Computing Consortium group highlights the potential for future collaborative research efforts across industries for faster results.
3. Tech Industry Contribution in Healthcare - NVIDIA's contribution of their SaturnV supercomputer and GPUs to COVID-19 research highlights the potential for the tech industry to increase involvement in healthcare efforts.
Industry Implications
1. Healthcare - NVIDIA's contribution to COVID-19 research and participation in the COVID-19 High Performance Computing Consortium group highlights the potential for increased tech industry involvement in healthcare research and solutions.
2. Technology - The allocation of NVIDIA's SaturnV supercomputer and GPUs to COVID-19 research showcases the impact that technology companies can make in medical research, presenting disruption opportunities across industries.
3. Research - The collaborative efforts within the COVID-19 High Performance Computing Consortium highlights the potential for future opportunities for research across industries and fields.